Thank you for subscribing!
Next Investors Jun 11, 2021
Creso Pharma (ASX:CPH) today announced its listing in the US, and the market is opening in around 12 hours - the US pool of investors is huge and they have a big appetite for psychedelics and cannabis stocks.
Next Investors Mar 01, 2021
Creso Pharma (ASX: CPH | FRA: 1X8) is set to distribute its range of CBD and hemp animal health anibidiol® products throughout the US, following a deal signed with CERES Natural Remedies.
Finfeed Archived Dec 08, 2020
Stocks were impacted last night as COVID-19 infections swept through the US again, putting the fear of further restrictions into investors.
Finfeed Archived Aug 27, 2020
Futures markets point to a turnaround today, largely reflecting strength in overseas markets as both the NASDAQ and the S&P 500 continued to set record highs. However the gain may be a little suppressed given the escalating geopolitical tensions between Australia and China stemming from a review announced yesterday by the Morrison government.
Get expert stock analysis direct in your inbox
Finfeed Archived Aug 24, 2020
Mixed leads from overseas with European markets down and US markets rallying, which could see a fairly uncertain start to the week.
Finfeed Archived Aug 19, 2020
Positive earnings results and news of an imminent US stimulus package should spur the markets forward. However, it may be a little too early to factor in potential upside given that the legislations has not yet been passed.
Finfeed Archived Aug 11, 2020
With most markets gaining ground overnight, one would expect another positive day, but the ASX SPI200 Futures Index is only up two points to 6072 points.
Finfeed Archived Aug 07, 2020
Wall Street shrugged off a sluggish start to close higher as the Nasdaq soared above 11,000 points as investors remain bullish on stocks and hope for a new fiscal stimulus package.
Finfeed Archived Jul 31, 2020
US stocks traded mostly lower overnight while oil prices fell as government data highlighted the deep economic impacts of the pandemic.
Join Our Mailing List